Product hopping in the drug industry — lessons from Albuterol

; Feldman, William B.; and Tu, S. Sean Product hopping in the drug industry — lessons from Albuterol New England Journal of Medicine, 387 (13). 1153 - 1156. ISSN 0028-4793

Copy

Product hops to albuterol inhalers containing hydrofluoroalkane rather than chlorofluorocarbons cost payers and patients billions of dollars. Without patent and regulatory reform, this pattern is likely to be repeated.

Item Type	Article
Departments	Health Policy
DOI	10.1056/NEJMp2208613
Date Deposited	14 Oct 2022 09:09
URI	https://researchonline.lse.ac.uk/id/eprint/116986

Explore Further

https://www.lse.ac.uk/health-policy/people/dr-olivier-wouters (Author)
http://www.scopus.com/inward/record.url?scp=85139376162&partnerID=8YFLogxK (Scopus publication)
https://www.nejm.org/ (Official URL)

picture_as_pdf

picture_as_pdf
subject: Accepted Version
: Available under Creative Commons: Attribution-No Derivative Works 4.0

Download

Atom

BibTeX

OpenURL ContextObject in Span

OpenURL ContextObject

Dublin Core

MPEG-21 DIDL

Data Cite XML

EndNote

HTML Citation

METS

MODS

RIOXX2 XML

Reference Manager

Refer

ASCII Citation

Export

Downloads